BRL54443
CAS No. 57477-39-1
BRL54443 ( BRL 54443;BRL-54443 )
产品货号. M15098 CAS No. 57477-39-1
BRL54443 is a potent, releative selective 5-HT1E/1F agonist with Ki of 2/1 nM, respectively.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥389 | 有现货 |
|
10MG | ¥616 | 有现货 |
|
25MG | ¥1296 | 有现货 |
|
50MG | ¥2041 | 有现货 |
|
100MG | ¥3426 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称BRL54443
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述BRL54443 is a potent, releative selective 5-HT1E/1F agonist with Ki of 2/1 nM, respectively.
-
产品描述BRL54443 is a potent, releative selective 5-HT1E/1F agonist with Ki of 2/1 nM, respectively; shows low affinity for other receptors 5-HT1A (63 nM), 5-HT1B (126 nM), 5-HT1D (63 nM), 5-HT2A (1259 nM), 5-HT2B (100 nM), 5-HT2C (316 nM), 5-HT6 (>10,000 nM), 5-HT7 (>10,000 nM), D2 (501 nM), D3 (631 nM), and α1B-adrenoceptors (1259 nM); selectively stimulates 5-HT1E receptors and potently inhibits forskolin-dependent cAMP production with IC50 of 14 nM in DG membranes; significantly reduces formalin-induced flinching in rats.
-
同义词BRL 54443;BRL-54443
-
通路Endocrinology/Hormones
-
靶点5-HT Receptor
-
受体5-HT1A;5-HT1B;5-HT1D;5-HT1E;5-HT1F
-
研究领域Cardiovascular Disease
-
适应症——
化学信息
-
CAS Number57477-39-1
-
分子量230.31
-
分子式C14H18N2O
-
纯度>98% (HPLC)
-
溶解度DMSO: ≥ 51 mg/mL
-
SMILESCN1CCC(C2=CNC3=C2C=C(O)C=C3)CC1
-
化学全称1H-Indol-5-ol, 3-(1-methyl-4-piperidinyl)-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Klein MT, et al. J Pharmacol Exp Ther. 2011 Jun;337(3):860-7.
2. Klein MT,et al. Br J Pharmacol. 2012 Jun;166(4):1290-302.
3. Granados-Soto V, et al. Neuroscience. 2010 Jan 20;165(2):561-8.
2. Klein MT,et al. Br J Pharmacol. 2012 Jun;166(4):1290-302.
3. Granados-Soto V, et al. Neuroscience. 2010 Jan 20;165(2):561-8.
产品手册
关联产品
-
Sumatriptan succinat...
Sumatriptan succinate is a serotonin1 (5-HT1) receptor agonist, which is effective in the acute treatment of migraine headache.
-
Landipirdine
A novel 5-HT receptor antagonist for the treatment of Parkinson's disease.
-
Pardoprunox
Pardoprunox(SLV-308) is a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.